News | October 03, 2023
Briefs: Aurobindo Pharma and Balaxi Pharmaceuticals
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
New Board of Directors and management team at Suven Pharma also appointed
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Lupin has been exclusively marketing these brands in the Indian market since July 2021
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Subscribe To Our Newsletter & Stay Updated
